<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

A structural basis for bacterial evasion of antibody responses through inhibitory receptor targeting

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Group B Streptococcus (GBS; Streptococcus agalactiae) continues to be a primary cause of neonatal sepsis while also representing a significant pathogen among immunocompromised adults. This work reveals the structural basis behind a new GBS immune-evasion mechanism whereby the cell-wall–anchored [beta] protein (~130 kDa) interacts with human inhibitory receptors to diminish antibody-mediated effector responses. The [beta] protein functions as a ligand for leukocyte immunoglobulin-like receptor B3 (LILRB3) an ITIM-containing inhibitory receptor found on human myeloid cells that dampens Fc receptor–driven activation. Our observations provide a framework for defining the molecular-level details underpinning the [beta]-LILRB3 interaction and using this information to probe its functional consequences. Domain mapping combined with surface plasmon resonance experiments uncovered two separate regions within the [beta] protein B6C (residues 226-391) and B75KN (residues 504-789) that serve as independent LILRB3-binding domains, with both displaying nanomolar binding affinities. The B6C crystal structure, resolved to 2.05 Å, unveiled an extended four-helix bundle configuration spanning ~111 Å, which differed substantially from existing computational models. Solution structures of both B6C/LILRB3 and B75KN-CTD/LILRB3 complexes were characterized using small-angle X-ray scattering with size-exclusion chromatography (SEC-SAXS), demonstrating that each domain recognizes the D3-D4 region of LILRB3. Mutagenesis experiments based on structural insights pinpointed essential interface residues: K332 and R336 within B6C, along with L721, D722, and F740 in B75KN-CTD. These mutations selectively eliminated LILRB3 binding yet maintained interactions with additional host proteins such as complement Factor H. Analysis of the ternary complex via SEC-SAXS showed that individual [beta] protein molecules engage two LILRB3 ectodomains concurrently, establishing a 1:2 stoichiometry that facilitates receptor cross-linking. Investigation of biological consequences demonstrated that [beta] protein-induced LILRB3 clustering inhibits antibody-mediated neutrophil activation and bacterial killing, thereby promoting bacterial persistence. This mechanism exhibits species specificity, as the [beta] protein cannot bind the murine ortholog PIR-B. Additionally, naturally existing LILRB3 variants within the D3-D4 domain entirely abolished [beta] protein recognition, indicating that host genetic diversity could modulate GBS infection outcomes. In summary, we provide the initial structural descriptions of a mechanism used by a prominent bacterial pathogen to exploit human inhibitory receptors and thereby overcome antibody-based immunity. Uncovering this new virulence mechanism advances our comprehension of GBS pathogenesis and offers potential avenues for innovative therapeutic strategies. It also provides a rationale for investigating similar evasion mechanisms in diverse host/pathogen interactions.

Description

Keywords

Immune evasion, Group B Streptococcus, Leukocyte immunoglobulin-like receptor B3, Neutrophil

Graduation Month

December

Degree

Doctor of Philosophy

Department

Biochemistry and Molecular Biophysics Interdepartmental Program

Major Professor

Brian V. Geisbrecht

Date

Type

Dissertation

Citation

Endorsement

Review

Supplemented By

Referenced By